VVigilance Weekly공개 리포트 보기
← 이번 주 리포트
dabigatran우선순위 중간ICSR 검토기타

LITERATURE DETAIL · PMID 42620299

Safety and effectiveness of dabigatran vs rivaroxaban in nonvalvular atrial fibrillation patients at nutritional risk.

Safety and effectiveness of dabigatran vs rivaroxaban in nonvalvular atrial fibrillation patients at nutritional risk.

저자
Linhao Liu, Hangkuan Liu, Geru Aa, Jingbo Yang, Zhiqiang Zhang, Tianqi Yang
저널
Research and practice in thrombosis and haemostasis
공개일
2026 Jul
연구 유형
기타
DOI
10.1016/j.rpth.2026.106865

문헌 요약

Malnutrition is a prevalent comorbidity in nonvalvular atrial fibrillation (NVAF), yet comparative evidence on oral anticoagulants in this vulnerable population is scarce. We aimed to compare the safety and effectiveness of dabigatran with those of rivaroxaban in NVAF patients at nutritional risk. This new-user, active-comparator cohort study utilized dat…

PV 검토 포인트

개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.

PubMed에서 원문 정보 보기